Page last updated: 2024-08-24

irinotecan and Mixed Tumor, Mesodermal

irinotecan has been researched along with Mixed Tumor, Mesodermal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azevedo, P; Deavers, MT; Freedman, RS; Kavanagh, JJ; Kudelka, AP; Lu, K; Verschraegen, CF	1

Other Studies

1 other study(ies) available for irinotecan and Mixed Tumor, Mesodermal

Article	Year
Malignant mixed mesodermal tumor of the ovary treated with a cisplatin-irinotecan combination: case report. European journal of gynaecological oncology, 2001, Volume: 22, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Enzyme Inhibitors; Female; Humans; Irinotecan; Middle Aged; Mixed Tumor, Mesodermal; Ovarian Neoplasms; Remission Induction; Topoisomerase I Inhibitors	2001

Article

Year

Malignant mixed mesodermal tumor of the ovary treated with a cisplatin-irinotecan combination: case report.

European journal of gynaecological oncology, 2001, Volume: 22, Issue:5

Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Enzyme Inhibitors; Female; Humans; Irinotecan; Middle Aged; Mixed Tumor, Mesodermal; Ovarian Neoplasms; Remission Induction; Topoisomerase I Inhibitors

2001